Viewing Study NCT02684032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT02684032
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2016-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Sponsor: Celcuity Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PI3K (phosphoinositide 3-kinase) View
None mTOR (mechanistic target of rapamycin) View
None PI3K/mTOR View
None metastatic breast cancer (MBC) View
None ER+ (estrogen receptor positive) View
None HER2- (human epidermal growth factor receptor 2 negative) View